Rare human Caspase-6-R65W and Caspase-6-G66R variants identify a novel regulatory region of Caspase-6 activity

[1]  E. Hamel,et al.  Caspase vinyl sulfone small molecule inhibitors prevent axonal degeneration in human neurons and reverse cognitive impairment in Caspase-6-overexpressing mice , 2017, Molecular Neurodegeneration.

[2]  J. Hardy,et al.  Caspase-6 Undergoes a Distinct Helix-Strand Interconversion upon Substrate Binding* , 2017, The Journal of Biological Chemistry.

[3]  Julia E. Seaman,et al.  Cacidases: caspases can cleave after aspartate, glutamate and phosphoserine residues , 2016, Cell Death and Differentiation.

[4]  J. Hardy,et al.  Reprogramming Caspase-7 Specificity by Regio-Specific Mutations and Selection Provides Alternate Solutions for Substrate Recognition. , 2016, ACS chemical biology.

[5]  C. Craik,et al.  Quantitative MS-based enzymology of caspases reveals distinct protein substrate specificities, hierarchies, and cellular roles , 2016, Proceedings of the National Academy of Sciences.

[6]  L. Galluzzi,et al.  Caspases Connect Cell-Death Signaling to Organismal Homeostasis. , 2016, Immunity.

[7]  N. Beauchemin,et al.  Inflammation-Induced Tumorigenesis in Mouse Colon Is Caspase-6 Independent , 2014, PloS one.

[8]  P. Swartz,et al.  Modifying Caspase-3 Activity by Altering Allosteric Networks , 2014, Biochemistry.

[9]  C. Klein,et al.  Human Procaspase-1 Variants with Decreased Enzymatic Activity Are Associated with Febrile Episodes and May Contribute to Inflammation via RIP2 and NF-κB Signaling , 2014, The Journal of Immunology.

[10]  C. Deppmann,et al.  Caspase-mediated cleavage of actin and tubulin is a common feature and sensitive marker of axonal degeneration in neural development and injury , 2014, Acta neuropathologica communications.

[11]  E. Hamel,et al.  Caspase-6 activity in the CA1 region of the hippocampus induces age-dependent memory impairment , 2014, Cell Death and Differentiation.

[12]  Xianrui Zhao,et al.  Tailoring Small Molecules for an Allosteric Site on Procaspase‐6 , 2013, ChemMedChem.

[13]  J. Hardy,et al.  A multipronged approach for compiling a global map of allosteric regulation in the apoptotic caspases. , 2014, Methods in enzymology.

[14]  S. Albrecht,et al.  Expression and Activation of Caspase-6 in Human Fetal and Adult Tissues , 2013, PloS one.

[15]  D. Bennett,et al.  Caspase-6 activity predicts lower episodic memory ability in aged individuals , 2013, Neurobiology of Aging.

[16]  J. Ramsey,et al.  Distinct Pathways Mediate Axon Degeneration during Apoptosis and Axon-Specific Pruning , 2013, Nature Communications.

[17]  M. Gahr,et al.  Naturally Occurring Genetic Variants of Human Caspase‐1 Differ Considerably in Structure and the Ability to Activate Interleukin‐1β , 2013, Human mutation.

[18]  Brandon J. Bravo,et al.  Mechanistic and Structural Understanding of Uncompetitive Inhibitors of Caspase-6 , 2012, PloS one.

[19]  D. O'Leary,et al.  A Caspase Cascade Regulating Developmental Axon Degeneration , 2012, The Journal of Neuroscience.

[20]  J. Cavanagh,et al.  Structural insights into the calcium‐dependent interaction between calbindin‐D28K and caspase‐3 , 2012, FEBS letters.

[21]  J. Hardy,et al.  Zinc-mediated Allosteric Inhibition of Caspase-6* , 2012, The Journal of Biological Chemistry.

[22]  Ole A. Andreassen,et al.  A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline , 2012, Nature.

[23]  Karen Stanger,et al.  Allosteric peptides bind a caspase zymogen and mediate caspase tetramerization. , 2012, Nature chemical biology.

[24]  D. Ehrnhoefer,et al.  Rescue from excitotoxicity and axonal degeneration accompanied by age-dependent behavioral and neuroanatomical alterations in caspase-6-deficient mice. , 2012, Human molecular genetics.

[25]  J. Hardy,et al.  Phosphorylation regulates assembly of the caspase-6 substrate-binding groove. , 2012, Structure.

[26]  Y. Gao,et al.  Inhibitory Mechanism of Caspase-6 Phosphorylation Revealed by Crystal Structures, Molecular Dynamics Simulations, and Biochemical Assays* , 2012, The Journal of Biological Chemistry.

[27]  J. Hardy,et al.  Substrate-induced conformational changes occur in all cleaved forms of caspase-6. , 2011, Journal of molecular biology.

[28]  W. Mi,et al.  Crystal structures of human caspase 6 reveal a new mechanism for intramolecular cleavage self‐activation , 2010, EMBO reports.

[29]  A. LeBlanc,et al.  Familial amyloid precursor protein mutants cause caspase-6-dependent but amyloid β-peptide-independent neuronal degeneration in primary human neuron cultures. , 2010, Cell Death and Disease.

[30]  Sami Mahrus,et al.  Activation of Specific Apoptotic Caspases with an Engineered Small-Molecule-Activated Protease , 2010, Cell.

[31]  D. Bennett,et al.  Identification of Caspase-6-Mediated Processing of the Valosin Containing Protein (p97) in Alzheimer's Disease: A Novel Link to Dysfunction in Ubiquitin Proteasome System-Mediated Protein Degradation , 2010, The Journal of Neuroscience.

[32]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[33]  B. Winblad,et al.  Caspase-6 Activation in Familial Alzheimer Disease Brains Carrying Amyloid Precursor Protein or Presenilin I or Presenilin II Mutations , 2009, Journal of neuropathology and experimental neurology.

[34]  A. D'arcy,et al.  The crystal structure of caspase-6, a selective effector of axonal degeneration. , 2009, The Biochemical journal.

[35]  M. Grütter,et al.  Structural and biochemical studies on procaspase-8: new insights on initiator caspase activation. , 2009, Structure.

[36]  A. LeBlanc,et al.  Self-activation of Caspase-6 in vitro and in vivo: Caspase-6 activation does not induce cell death in HEK293T cells. , 2009, Biochimica et biophysica acta.

[37]  Marc Tessier-Lavigne,et al.  APP binds DR6 to trigger axon pruning and neuron death via distinct caspases , 2009, Nature.

[38]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[39]  R. Flavell,et al.  Caspase 6 Regulates B Cell Activation and Differentiation into Plasma Cells1 , 2008, The Journal of Immunology.

[40]  A. LeBlanc,et al.  Targets of Caspase-6 Activity in Human Neurons and Alzheimer Disease*S , 2008, Molecular & Cellular Proteomics.

[41]  D. Bennett,et al.  Activation of caspase-6 in aging and mild cognitive impairment. , 2007, The American journal of pathology.

[42]  J. Mikolajczyk,et al.  Design, synthesis, and evaluation of aza-peptide Michael acceptors as selective and potent inhibitors of caspases-2, -3, -6, -7, -8, -9, and -10. , 2006, Journal of medicinal chemistry.

[43]  S. Albrecht,et al.  Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease. , 2004, The American journal of pathology.

[44]  J. Mikolajczyk,et al.  Design, synthesis, and evaluation of aza-peptide epoxides as selective and potent inhibitors of caspases-1, -3, -6, and -8. , 2004, Journal of medicinal chemistry.

[45]  Christophe Briand,et al.  Crystal Structure of Caspase-2, Apical Initiator of the Intrinsic Apoptotic Pathway* , 2003, Journal of Biological Chemistry.

[46]  G. Salvesen,et al.  Expression, Purification, and Characterization of Caspases , 2002, Current protocols in protein science.

[47]  J Downward,et al.  Caspase-6 is the direct activator of caspase-8 in the cytochrome c-induced apoptosis pathway: absolute requirement for removal of caspase-6 prodomain , 2002, Cell Death and Differentiation.

[48]  R. Liddington,et al.  Dimer formation drives the activation of the cell death protease caspase 9 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Y. Lazebnik,et al.  Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation , 2000, Nature Medicine.

[50]  K. Wilson,et al.  The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivity. , 2000, Chemistry & biology.

[51]  R. Flavell,et al.  Caspase knockouts: matters of life and death , 1999, Cell Death and Differentiation.

[52]  H. Stennicke,et al.  Catalytic properties of the caspases , 1999, Cell Death and Differentiation.

[53]  A. Tomasselli,et al.  The atomic-resolution structure of human caspase-8, a key activator of apoptosis. , 1999, Structure.

[54]  M. Grütter,et al.  The three-dimensional structure of caspase-8: an initiator enzyme in apoptosis. , 1999, Structure.

[55]  C. Bergeron,et al.  Caspase-6 Role in Apoptosis of Human Neurons, Amyloidogenesis, and Alzheimer’s Disease* , 1999, The Journal of Biological Chemistry.

[56]  G. Salvesen,et al.  Biochemical Characteristics of Caspases-3, -6, -7, and -8* , 1997, The Journal of Biological Chemistry.

[57]  G M Cohen,et al.  Caspases: the executioners of apoptosis. , 1997, The Biochemical journal.

[58]  N. Thornberry,et al.  A Combinatorial Approach Defines Specificities of Members of the Caspase Family and Granzyme B , 1997, The Journal of Biological Chemistry.

[59]  S. Srinivasula,et al.  The Ced-3/Interleukin 1β Converting Enzyme-like Homolog Mch6 and the Lamin-cleaving Enzyme Mch2α Are Substrates for the Apoptotic Mediator CPP32* , 1996, The Journal of Biological Chemistry.

[60]  N. Thornberry,et al.  The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis , 1996, Nature Structural Biology.

[61]  M. Murcko,et al.  Structure and mechanism of interleukin-1 beta converting enzyme. , 1994, Nature.

[62]  F. E. G. Cox,et al.  Matters of life and death , 1990, Nature.

[63]  P. Y. Chou,et al.  Empirical predictions of protein conformation. , 1978, Annual review of biochemistry.